A review of cancer diagnoses between 2007 and 2019 among individuals aged <25 years found differences between Māori and Europeans in incident cancers and survival. Data were extracted from the New Zealand Cancer Registry. Māori were more likely to be diagnosed with poor-prognosis cancers, such as brain cancer, and less likely to be diagnosed with good-prognosis cancers, such as Hodgkin’s lymphoma and melanoma. Māori were less likely to survive cancer even after adjusting for differences in cancer type. The study authors noted that further quantitative and qualitative research could inform actions aimed at addressing disparities and improving survival for Māori.
Again, important that we monitor cancer types, rates and mortality by ethnicity. As the authors note, kaupapa Māori approaches to future research, and co-design with Māori in the design of interventions, are needed to ensure equity focused action and outcomes.
Independent commentary by Dr. Matire Hardwood
Dr Matire Harwood (Ngapuhi) has worked in Hauora Māori, primary health and rehabilitation settings as clinician and researcher since graduating from Auckland Medical School in 1994. She also holds positions on a number of boards, committees and advisory groups including the Health Research Council. Matire lives in Auckland with her whānau including partner Haunui and two young children Te Rangiura and Waimarie.
Research Review publications are intended for New Zealand health professionals.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.
